Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Director/PDMR Shareholding

3 Sep 2008 13:16

RNS Number : 6636C
F&C Private Equity Trust PLC
03 September 2008
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

Β 

(1)

AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2)

AnΒ issuerΒ making a notification in respect of a derivative relating to theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.Β 

(3)

AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.Β 

(4)

AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β 

Β 

Please complete all relevant boxes in block capital letters.

1. Name of theΒ issuer

F&C Private Equity Trust plc

2. State whether the notification relates to (i) a transaction notified in accordance withΒ DRΒ 3.1.4R(1)(a); or

(ii)Β DRΒ 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; orΒ 

(iii) both (i) and (ii)

Related to (iii)

3. Name ofΒ person discharging managerial responsibilities/director

Elizabeth Kennedy

4. State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

N/A

5. Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

Beneficial interest

6. Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

OrdinaryΒ shares

7. Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

As 4

8 State the nature of the transaction

Purchase

9. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

15,000

10. Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

0.02%

11. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

N/A

12. Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

N/A

13. Price perΒ shareΒ or value of transaction

Β£1.82

14. Date and place of transaction

2 SeptemberΒ 2008

15. Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage

30,000Β  0.04%

16. Date issuer informed of transaction

2 SeptemberΒ 2008

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17 Date of grant

18. Period during which or date on which it can be exercised

19. Total amount paid (if any) for grant of the option

20. Description ofΒ sharesΒ or debentures involved (classΒ and number)

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

22. Total number ofΒ sharesΒ or debentures over which options held following notification

23. Any additional information

24. Name of contact and telephone number for queries

Steven Ross

0207 628 8000

Name and signature of duly authorised officer ofΒ issuerΒ responsible for making notification

Martin Cassels

Date of notification

3 SeptemberΒ 2008

ENDΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSBDGDCSBGGGIX
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.